| First Author | Dolens AC | Year | 2020 |
| Journal | EMBO Rep | Volume | 21 |
| Issue | 5 | Pages | e49006 |
| PubMed ID | 32255245 | Mgi Jnum | J:292744 |
| Mgi Id | MGI:6448860 | Doi | 10.15252/embr.201949006 |
| Citation | Dolens AC, et al. (2020) Distinct Notch1 and BCL11B requirements mediate human gammadelta/alphabeta T cell development. EMBO Rep 21(5):e49006 |
| abstractText | gammadelta and alphabeta T cells have unique roles in immunity and both originate in the thymus from T-lineage committed precursors through distinct but unclear mechanisms. Here, we show that Notch1 activation is more stringently required for human gammadelta development compared to alphabeta-lineage differentiation and performed paired mRNA and miRNA profiling across 11 discrete developmental stages of human T cell development in an effort to identify the potential Notch1 downstream mechanism. Our data suggest that the miR-17-92 cluster is a Notch1 target in immature thymocytes and that miR-17 can restrict BCL11B expression in these Notch-dependent T cell precursors. We show that enforced miR-17 expression promotes human gammadelta T cell development and, consistently, that BCL11B is absolutely required for alphabeta but less for gammadelta T cell development. This study suggests that human gammadelta T cell development is mediated by a stage-specific Notch-driven negative feedback loop through which miR-17 temporally restricts BCL11B expression and provides functional insights into the developmental role of the disease-associated genes BCL11B and the miR-17-92 cluster in a human context. |
